Clínic Barcelona

Non-coding DNA implicated in type 2 diabetes

Variations in non-coding sections of the genome might be important contributors to type 2 diabetes risk, according to a new study. DNA sequences that don’t encode proteins were once dismissed as “junk DNA”, but scientists are increasingly discovering that some regions are important for controlling which genes are switched on. The new study, published in Nature Genetics, is one of the first to show how such regions, called regulatory elements, can influence people’s risk of disease. The present work is a collaborative effort with three first authors: Lorenzo Pasquali (IDIBAPS-CIBERDEM), Kyle J Gaulton (University of Oxford), Santiago A Rodríguez-Seguí (former IDIBAPS researcher and now at Universidad de Buenos Aires), with Dr. Jorge Ferrer (IDIBAPS_CIBERDEM-Imperial College London) as its last author. The present work, led by IDIBAPS' investigators, was supported by the CIBER of Diabetes and Metabolic Diseases (CIBERDEM) and investigators from CSIC.